• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Coloplast A/S Board Members’ Share Trading Announcement

    GLOBENEWSWIRE

    Coloplast A/S - Decisions at the Annual General Meeting 2024

    GLOBENEWSWIRE

    Coloplast divests core Skin Care product portfolio

    GLOBENEWSWIRE

    Kerecis Included on Final LCD for Diabetic Foot Ulcers Coverage

    GLOBENEWSWIRE

    Change in management board

    GLOBENEWSWIRE

    Coloplast A/S - Notice of Annual General Meeting 2024

    GLOBENEWSWIRE

    Coloplast A/S - Full-Year Financial Results 2023/24

    GLOBENEWSWIRE

    Coloplast Annual Report 2023/24 & Remuneration Report 2023/24

    GLOBENEWSWIRE

    Coloplast Finance B.V. - Annual Report, 2023/24

    GLOBENEWSWIRE

    Coloplast Expands Executive Leadership in Announcement No. 05/2024

    GLOBENEWSWIRE

    Coloplast A/S - Financial Calendar 2024-25

    GLOBENEWSWIRE

    Coloplast A/S Reports Trading By Board And Executives

    GLOBENEWSWIRE

    Coloplast Reports Insider Trading Activity

    GLOBENEWSWIRE

    Coloplast A/S - Trading In Shares By Associated Persons

    GLOBENEWSWIRE

    Coloplast Reports Trading by Board Members, Executives, or Associates

    GLOBENEWSWIRE

    Coloplast Reports Trading In Shares By Board Members And Executives

    GLOBENEWSWIRE

    Coloplast A/S - Interim Financial Report, 9M 2023/24

    GLOBENEWSWIRE

    Coloplast Invites To June 6 Meet The Management Event

    GLOBENEWSWIRE

    Coloplast expands its Luja„ portfolio with next generation catheter for women

    GLOBENEWSWIRE

    Trading in Coloplast shares by board members, executives or associated persons

    GLOBENEWSWIRE

    Trading in Coloplast shares by board members, executives or associated persons

    GLOBENEWSWIRE

    Trading in Coloplast shares by board members, executives or associated persons

    GLOBENEWSWIRE

    Trading in Coloplast shares by board members, executives or associated persons

    GLOBENEWSWIRE

    Coloplast A/S - Interim Financial Report, Q1 2023/24

    GLOBENEWSWIRE

    Coloplast launches Peristeen® Light for people with bowel disorders

    GLOBENEWSWIRE

    Coloplast Finance B.V. - Interim Financial Report, Q1 2023/24

    GLOBENEWSWIRE

    Coloplast A/S - Allocation of Share Options

    GLOBENEWSWIRE

    Coloplast launches Biatain® Silicone Fit for pressure injury prevention

    GLOBENEWSWIRE

    Coloplast Finance B.V. - Decisions at the Annual General Meeting

    GLOBENEWSWIRE

    Coloplast Finance B.V. - Change of Auditor

    GLOBENEWSWIRE

    Coloplast A/S - Q1 2023/24 Earnings Release

    GLOBENEWSWIRE

    Coloplast A/S - Decisions at the Annual General Meeting 2023

    GLOBENEWSWIRE

    Coloplast A/S - Articles of Association

    GLOBENEWSWIRE

    Coloplast A/S - Change of auditor

    GLOBENEWSWIRE

    Coloplast A/S - Financial Calendar 2023-24

    GLOBENEWSWIRE

    Coloplast announces registration of share capital increase of 12.2 new B shares

    GLOBENEWSWIRE

    Trading in Coloplast shares by board members, executives or associated persons

    GLOBENEWSWIRE

    Coloplast A/S - Coloplast completes the acquisition of Kerecis

    GLOBENEWSWIRE

    Coloplast completes the acquisition of Kerecis

    GLOBENEWSWIRE

    Major shareholder notification

    GLOBENEWSWIRE

    Trading in Coloplast shares by board members, associated persons

    GLOBENEWSWIRE

    Coloplast - Announcement no. 04/2023 - Interim Financial Report, 9M 2022/2023

    GLOBENEWSWIRE

    Coloplast - Announcement no. 04/2023 - Interim Financial Report 9M 2022/23

    GLOBENEWSWIRE

    Coloplast announces agreement to acquire Kerecis and raises growth expectations

    GLOBENEWSWIRE

    Coloplast B.V. - Announcement no. 03/2023 - Interim Financial Report H1 2022/23

    GLOBENEWSWIRE

    New clinical study demonstrates significant improvement in pulmonary health

    GLOBENEWSWIRE

    Study shows significant improvement in bladder emptying with Coloplast`s Luja

    GLOBENEWSWIRE

    Coloplast - Announcement no. 01/2023 Interim Financial Report, Q1 2022/23

    GLOBENEWSWIRE

    Coloplast launches catheter designed to reduce risk of urinary tract infections

    GLOBENEWSWIRE

    Coloplast A/S - Allocation of Share Options

    GLOBENEWSWIRE

    Coloplast B.V. - Announcement no. 02/2023 - Interim Financial Report Q1 2022/23

    GLOBENEWSWIRE

    Coloplast Finance B.V. - Decisions at the Annual General Meeting

    GLOBENEWSWIRE

    Coloplast Finance B.V. - 9M Interim Financial Report 2021/2022

    GLOBENEWSWIRE

    Coloplast`s Meet the Management event on 31 August 2022 - register by 5 August

    GLOBENEWSWIRE

    Coloplast awarded AscenDrive Agreement for Ostomy Products with Premier, Inc.

    GLOBENEWSWIRE

    Disclosure of Home Member State by Coloplast Finance B.V.

    GLOBENEWSWIRE

    Coloplast announces the successful issuance of EUR 2.2 billion senior notes

    GLOBENEWSWIRE

    Coloplast announces the establishment of its Euro Medium Term Note programme

    GLOBENEWSWIRE

    Coloplast delivers a solid Q2 with 7% organic growth and a 31% EBIT margin

    GLOBENEWSWIRE

    Coloplast A/S - Announcement no. 04/2022 Interim Financial Report, H1 2021/22

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.